Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders' Equity

v3.8.0.1
Consolidated Statements of Shareholders' Equity - 9 months ended Sep. 30, 2017 - USD ($)
$ in Thousands
Capital Stock
Warrants
Contributed Surplus [Member]
Accumulated Other Comprehensive Income
Deficit
Total
Beginning Balance at Dec. 31, 2016 $ 174,902 $ 4,109 $ 15,201 $ 3,604 $ (161,584) $ 36,232
Beginning Balance (in shares) at Dec. 31, 2016 143,676,384         143,676,384
Exercise of stock options $ 518   (169)     $ 349
Exercise of stock options (in shares) 549,952         549,952
Common shares issued for cash, net $88 of issue costs $ 1,081         $ 1,081
Common shares issued for cash, net of issue costs (in shares) 1,536,169         1,536,169
Redemption of vested RSUs $ 152   (221)     $ (69)
Redemption of vested RSUs (in shares) 246,700          
Non-cash stock compensation     705     705
Net loss and comprehensive (loss) income       66 3,502 3,568
Ending Balance at Sep. 30, 2017 $ 176,653 $ 4,109 $ 15,516 $ 3,670 $ (158,082) $ 41,866
Ending Balance (in shares) at Sep. 30, 2017 146,009,205         146,009,205